T1	HMM 0 27	Safety and pharmacokinetics
T2	HMM 246 273	pharmacokinetics and safety
T3	HMM 903 1007	HIVIG rapidly cleared maternal serum immune complex-dissociated p24 antigen, and plasma HIV-1 RNA levels
T4	HMM 1038 1062	adverse clinical effects
T5	HMM 1126 1186	adverse hematologic, blood chemistry, or immunologic effects
T6	HMM 1207 1221	well-tolerated
T7	HMM 1328 1344	pharmacokinetics
